Pharmasset (VRUS) ratings and price targets.
Leerink downgraded Pharmasset from an “Outperform” rating to a “Market Perform” rating.
Canaccord Genuity downgraded Pharmasset from a “Buy” rating to a “Hold” rating.
JPMorgan Chase & Co. (NYSE:JPM) downgraded Pharmasset from an “Overweight” rating to a “Neutral” rating. They have a price target of $137.00 on the company.
Wells Fargo & Co. (NYSE:WFC) downgraded Pharmasset from an “Outperform” rating to a “Market Perform” rating.
No comments:
Post a Comment